Medtronic CoreValve Evolut TAVR device in the Medtronic booth at TCT 2023. Photo by Dave Fornell

Medtronic’s TAVR technology received a significant amount of attention during the very first New York Valves conference in New York City. Research focused on patients with small annuli as well as how five-year outcomes compare to surgery. 

Jagmeet Singh, MD, PhD, Professor of Medicine, Harvard Medical School, and Founding Director of the Resynchronization and Advanced Cardiac Therapeutics Program at Mass General Hospital, delivered a key note address at HRS 2024 on the future of artificial intelligence in EP and AI applications in cardiology. #HRS #EPeeps #HRS2024 #HRS24 #HealthAI

Jagmeet Singh, MD, delivered a keynote address at HRS 2024 on the future of AI in electrophysiology. He spoke to Cardiovascular Business, sharing additional thoughts about the topic.

healthcare money economics dollar stethoscope acquire merger

The FTC and other federal agencies launched a public inquiry to see how physicians, patients and other stakeholders felt about the rising influence of private equity in healthcare. Based on the public comments available online, many in the industry are concerned about the trend's long-term impact on patient care. 

cardiologist viewing heart data

Researchers explored five-year data from more than 1,300 TAVR patients treated with a balloon-expandable Sapien 3 valve, sharing their findings at New York Valves 2024: The Structural Heart Summit.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."